awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50903375-3C2D3813-D6FB-4FDA-BBA1-F454D6D78214
Q50903375-3C2D3813-D6FB-4FDA-BBA1-F454D6D78214
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50903375-3C2D3813-D6FB-4FDA-BBA1-F454D6D78214
The Finnish national guideline for diagnosis, treatment and follow-up of patients with wet age-related macular degeneration.
P2860
Q50903375-3C2D3813-D6FB-4FDA-BBA1-F454D6D78214
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50903375-3C2D3813-D6FB-4FDA-BBA1-F454D6D78214
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0e022891f9779fef9ecdd6125de9509f118a431c
P2860
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis.